Targeting HER3 using mono- and bispecific antibodies or alternative scaffolds

Por Malm, Magdalena, Frejd, Fredrik Y., Ståhl, Stefan, Löfblom, John
Publicado no MAbs (2016)

Cellular Effects of HER3-Specific Affibody Molecules

Por Göstring, Lovisa, Malm, Magdalena, Höidén-Guthenberg, Ingmarie, Frejd, Fredrik Y., Ståhl, Stefan, Löfblom, John, Gedda, Lars
Publicado em 2012

Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification

Por Malm, Magdalena, Kronqvist, Nina, Lindberg, Hanna, Gudmundsdotter, Lindvi, Bass, Tarek, Frejd, Fredrik Y., Höidén-Guthenberg, Ingmarie, Varasteh, Zohreh, Orlova, Anna, Tolmachev, Vladimir, Ståhl, Stefan, Löfblom, John
Publicado em 2013

Correction: Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification

Por Malm, Magdalena, Kronqvist, Nina, Lindberg, Hanna, Gudmundsdotter, Lindvi, Bass, Tarek, Frejd, Fredrik Y., Höidén-Guthenberg, Ingmarie, Varasteh, Zohreh, Orlova, Anna, Tolmachev, Vladimir, Ståhl, Stefan, Löfblom, John
Publicado em 2013